Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies

被引:213
|
作者
Wang, Tao [1 ]
Upponi, Jaydev R. [1 ]
Torchilin, Vladimir P. [1 ]
机构
[1] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA
关键词
Multifunctional non-viral gene vectors; Delivery barriers; Long-circulation; Targeted delivery; Cytoplamic delivery; Nuclear import; PLASMID-LIPID PARTICLES; ARGININE-RICH PEPTIDES; NUCLEAR-LOCALIZATION SIGNALS; SMALL INTERFERING RNA; TRANSFER IN-VITRO; NANO DEVICE MEND; INTRACELLULAR TRAFFICKING; DELIVERY-SYSTEM; ANTISENSE OLIGONUCLEOTIDES; EXTENDED CIRCULATION;
D O I
10.1016/j.ijpharm.2011.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene-based therapeutics hold great promise for medical advancement and have been used to treat various human diseases with mixed success. However, their therapeutic application in vivo is limited due largely to several physiological barriers. The design of non-viral gene vectors with the ability to overcome delivery obstacles is currently under extensive investigation. These efforts have placed an emphasis on the development of multifunctional vectors able to execute multiple tasks to simultaneously overcome both extracellular and intracellular obstacles. However, the assembly of these different functionalities into a single system to create multifunctional gene vectors faces many conflicts that largely limit the safe and efficient application of lipoplexes and polyplexes in a systemic delivery. In the review, we have described the dilemmas inherent in the design of a viable, non-viral gene vector equipped with multiple functionalities. The strategies directed towards individual delivery barriers are first summarized, followed by a focus on the design of so-called smart multifunctional vectors with the capability to overcome the delivery difficulties of gene medicines, including the so-called the "polycation dilemma", the "PEG dilemma" and the "package and release dilemma". (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:3 / 20
页数:18
相关论文
共 50 条
  • [1] Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
    Caffery, Breanne
    Lee, Jeoung Soo
    Alexander-Bryant, Angela A.
    NANOMATERIALS, 2019, 9 (01)
  • [2] Design of modular non-viral gene therapy vectors
    De Laporte, L
    Rea, JC
    Shea, LD
    BIOMATERIALS, 2006, 27 (07) : 947 - 954
  • [3] Non-viral and viral vectors for gene therapy
    Boulaiz, H
    Marchal, JA
    Prados, J
    Melguizo, C
    Aránega, A
    CELLULAR AND MOLECULAR BIOLOGY, 2005, 51 (01) : 3 - 22
  • [4] Non-viral vectors for gene delivery
    Bansal A.
    Himanshu
    Nanoscience and Nanotechnology - Asia, 2019, 9 (01): : 4 - 11
  • [5] Non-viral gene delivery: Multifunctional polyplexes as locally triggerable nonviral vectors
    J A Hubbell
    Gene Therapy, 2006, 13 : 1371 - 1372
  • [6] Strategies for cancer gene-delivery improvement by non-viral vectors
    Santana-Armas, Maria L.
    de Ilarduya, C. Tros
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 596
  • [7] Combining strategies to improve non-viral vectors
    Fricker, J
    MOLECULAR MEDICINE TODAY, 1998, 4 (08): : 323 - 323
  • [8] Viral and non-viral vectors for cancer gene therapy
    Cristiano, RJ
    ANTICANCER RESEARCH, 1998, 18 (5A) : 3241 - 3245
  • [9] Peptides as key components in the design of non-viral vectors for gene delivery
    Thomas, Joseph
    Punia, Kamia
    Montclare, Jin Kim
    PEPTIDE SCIENCE, 2021, 113 (02)
  • [10] Emerging non-viral vectors for gene delivery
    Chenfei Wang
    Chaolan Pan
    Haiyang Yong
    Feifei Wang
    Tao Bo
    Yitong Zhao
    Bin Ma
    Wei He
    Ming Li
    Journal of Nanobiotechnology, 21